Vermilion Therapeutics aims to create innovative new drugs from
Japanese science, and aims to innovate new modality and technology
in collaboration with academia science.
Dec. 02, 2021
New ”Photo-catalyst” results presented at the 40th annual meeting of Japanese Society for Dementia research
Nov. 12, 2021
Photo-Device Development: Research Collaboration agreement with Ushio Inc. , University of Tokyo, and Wakayama Medical University
Apr. 14, 2021
Our technology has been published in “Brain”.
Vermilion Therapeutics Inc. is aiming to research and develop new treatments for Alzheimer’s disease, Cardiac and Kidney Amyloidosis, Corona virus infections (SARS-CoV-2), and Solid tumors and malignant cancer.